Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women

The figure compares the costs inherent in each mode. One third of a consultation's costs are allocated to administration; this is taken as one cost unit, which happens to approximate to the average cost of one item on prescription. No account is taken of opportunity costs by the patient through loss of earnings or by the fact that the specialist clinic continues to function. Nevertheless, the model shows that referral as an outpatient, for example, may be seen to be a highly expensive management decision. Morbidity studies of general practice show that the referral option is exercised with a high degree of discrimination (about 1 in 10). The general practitioner thus plays a key role in "sparing" expensive specialist resources. Nevertheless, there is a wide range of variation, suggesting that there may be scope for creating a greater awareness of cost effectiveness in primary care. Issuing a prescription may be obviated by using the counselling mode, but at the expense of consulting time. The figure shows the relative insignificance of prescribing as a cost, yet this management option has received so much attention. We need a reappraisal of primary medical care costs in a fuller context, to include the general practice-hospital interface and the public.3 J D E KNOX University Department of General Practice, Westgate Health Centre, Dundee DD2 4AD

[1]  D. Meldrum,et al.  Biologic effects of transdermal estradiol. , 1986, The New England journal of medicine.

[2]  S. Kukreja,et al.  Effects of estradiol and progesterone on calcitonin secretion. , 1986, Endocrinology.

[3]  A. Jacob Entry to a health centre: conduct and outcome of a prospective study. , 1985, Family practice.

[4]  M. Whitehead,et al.  Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women. , 1985, American journal of obstetrics and gynecology.

[5]  W. Good,et al.  Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement. , 1985, American journal of obstetrics and gynecology.

[6]  J. Webster,et al.  Initial dose of enalapril in hypertension. , 1985, British medical journal.

[7]  S. Campbell,et al.  Regulation of calcium‐regulating hormones by exogenous sex steroids in early postmenopause , 1983, European journal of clinical investigation.

[8]  M. Sambhi,et al.  Estrogen replacement therapy by transdermal estradiol administration. , 1983, American journal of obstetrics and gynecology.

[9]  J. Coope Is oestrogen therapy effective in the treatment of menopausal depression? , 1981, The Journal of the Royal College of General Practitioners.

[10]  S. Morimoto,et al.  THE EFFECT OF OESTROGENS ON HUMAN CALCITONIN SECRETION AFTER CALCIUM INFUSION IN ELDERLY FEMALE SUBJECTS , 1980, Clinical endocrinology.

[11]  D. Feldman,et al.  Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. , 1978, Endocrinology.

[12]  P. Kelly,et al.  Role of hormonal factors in the pathogenesis of postmenopausal osteoporosis. , 1976, Israel journal of medical sciences.

[13]  L. Poller,et al.  Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. , 1975, British medical journal.

[14]  J. Gier,et al.  Chapter 4 – Lipids of the Red Cell Membrane , 1974 .

[15]  K. Hodgkin The evaluation of a direct nursing attachment in a North Edinburgh practice , 1973 .